Abbott India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 10, 2025, 8:52 pm

Market Cap	61,855 Cr.
Current Price	29,108
High / Low	31,900/25,200
Stock P/E	46.4
Book Value	1,657
Dividend Yield	1.41 %
ROCE	46.0 %
ROE	34.9 %
Face Value	10.0
PEG Ratio	3.30

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Abbott India Ltd

Competitors of Abbott India Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lactose (India) Ltd	148 Cr.	105	247/84.3	21.4	36.5	0.00 %	18.0 %	15.5 %	10.0
MPS Pharmaa Ltd	5.50 Cr.	2.88	4.33/2.88		0.80	0.00 %	9.15 %	34.9 %	10.0
Gujarat Themis Biosyn Ltd	2,663 Cr.	244	390/192	50.6	20.5	0.27 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	44.7 Cr.	60.2	94.9/44.5	15.1	11.9	0.00 %	9.72 %	3.44 %	10.0
Gujarat Inject (Kerala) Ltd	37.7 Cr.	25.8	29.0/10.6	38.5	6.64	0.00 %	2.65 %	2.08 %	10.0
Industry Average	16,865.19 Cr	1,040.20		40.33	182.59	0.37%	16.01%	16.31%	6.24

All Competitor Stocks of Abbott India Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	1,224	1,255	1,304	1,379	1,322	1,343	1,479	1,494	1,437	1,439	1,558	1,633	1,614
Expenses	955	961	1,034	1,036	1,010	1,063	1,124	1,113	1,049	1,109	1,167	1,194	1,178
Operating Profit	269	294	270	343	312	280	355	381	388	330	391	439	436
OPM %	22%	23%	21%	25%	24%	21%	24%	25%	27%	23%	25%	27%	27%
Other Income	19	21	27	34	44	50	56	56	56	81	67	60	72
Interest	4	5	4	4	4	4	3	3	3	3	3	2	2
Depreciation	17	17	17	17	18	17	17	18	18	18	18	18	18
Profit before tax	267	292	275	355	335	308	390	415	422	390	437	479	488
Tax %	25%	28%	25%	25%	26%	25%	26%	25%	26%	26%	25%	25%	26%
Net Profit	199	211	206	266	247	231	290	313	311	287	328	359	361
EPS in Rs	93.74	99.49	96.77	124.95	116.16	108.91	136.59	147.27	146.35	135.09	154.36	168.76	169.78

Last Updated: February 28, 2025, 3:59 pm

Below is a detailed analysis of the quarterly data for Abbott India Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 1,614.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,633.00 Cr. (Sep 2024) to 1,614.00 Cr., marking a decrease of 19.00 Cr..
For Expenses, as of Dec 2024, the value is 1,178.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,194.00 Cr. (Sep 2024) to 1,178.00 Cr., marking a decrease of 16.00 Cr..
For Operating Profit, as of Dec 2024, the value is 436.00 Cr.. The value appears to be declining and may need further review. It has decreased from 439.00 Cr. (Sep 2024) to 436.00 Cr., marking a decrease of 3.00 Cr..
For OPM %, as of Dec 2024, the value is 27.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 27.00%.
For Other Income, as of Dec 2024, the value is 72.00 Cr.. The value appears strong and on an upward trend. It has increased from 60.00 Cr. (Sep 2024) to 72.00 Cr., marking an increase of 12.00 Cr..
For Interest, as of Dec 2024, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 2.00 Cr..
For Depreciation, as of Dec 2024, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 18.00 Cr..
For Profit before tax, as of Dec 2024, the value is 488.00 Cr.. The value appears strong and on an upward trend. It has increased from 479.00 Cr. (Sep 2024) to 488.00 Cr., marking an increase of 9.00 Cr..
For Tax %, as of Dec 2024, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Sep 2024) to 26.00%, marking an increase of 1.00%.
For Net Profit, as of Dec 2024, the value is 361.00 Cr.. The value appears strong and on an upward trend. It has increased from 359.00 Cr. (Sep 2024) to 361.00 Cr., marking an increase of 2.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 169.78. The value appears strong and on an upward trend. It has increased from 168.76 (Sep 2024) to 169.78, marking an increase of 1.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 2:17 pm

Metric	Dec 2012	Mar 2014n n 15m	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	1,653	2,276	2,289	2,614	2,903	3,298	3,679	4,093	4,310	4,913	5,349	5,849	6,243
Expenses	1,451	2,009	1,977	2,250	2,505	2,774	3,074	3,336	3,388	3,832	4,143	4,396	4,648
Operating Profit	202	267	312	365	398	525	605	757	922	1,082	1,206	1,453	1,596
OPM %	12%	12%	14%	14%	14%	16%	16%	18%	21%	22%	23%	25%	26%
Other Income	33	49	48	50	57	117	113	114	81	83	154	248	281
Interest	0	0	0	3	2	4	2	9	18	19	16	12	10
Depreciation	19	22	15	14	16	16	17	60	58	66	70	71	72
Profit before tax	215	295	344	398	436	621	699	803	926	1,080	1,274	1,618	1,794
Tax %	33%	33%	34%	36%	37%	35%	36%	26%	25%	26%	25%	26%
Net Profit	145	198	229	255	277	401	450	593	691	799	949	1,201	1,334
EPS in Rs	68.10	93.39	107.75	120.12	130.19	188.82	211.93	279.04	325.04	375.87	446.80	565.30	627.99
Dividend Payout %	25%	25%	29%	29%	31%	29%	31%	90%	85%	73%	73%	73%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	11.35%	8.63%	44.77%	12.22%	31.78%	16.53%	15.63%	18.77%	26.55%
Change in YoY Net Profit Growth (%)	0.00%	-2.73%	36.14%	-32.55%	19.56%	-15.25%	-0.90%	3.14%	7.78%

Abbott India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	10%
5 Years:	10%
3 Years:	11%
TTM:	9%

Compounded Profit Growth
10 Years:	20%
5 Years:	22%
3 Years:	20%
TTM:	16%

Stock Price CAGR
10 Years:	22%
5 Years:	11%
3 Years:	18%
1 Year:	10%

Return on Equity
10 Years:	28%
5 Years:	30%
3 Years:	32%
Last Year:	35%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 6:30 pm

Month	Dec 2012	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	21	21	21	21	21	21	21	21	21	21	21	21	21
Reserves	626	767	916	1,174	1,366	1,672	1,987	2,410	2,581	2,799	3,167	3,678	3,500
Borrowings	0	0	0	0	0	0	0	175	153	152	113	83	60
Other Liabilities	260	351	436	421	679	723	932	940	1,086	1,253	1,254	1,411	1,481
Total Liabilities	907	1,139	1,374	1,616	2,066	2,416	2,941	3,547	3,840	4,224	4,556	5,193	5,063
Fixed Assets	109	98	96	108	110	81	105	270	251	271	237	225	216
CWIP	1	1	4	3	6	2	1	2	1	1	4	10	13
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	798	1,040	1,274	1,505	1,950	2,333	2,835	3,275	3,589	3,952	4,315	4,958	4,834
Total Assets	907	1,139	1,374	1,616	2,066	2,416	2,941	3,547	3,840	4,224	4,556	5,193	5,063

Below is a detailed analysis of the balance sheet data for Abbott India Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 21.00 Cr..
For Reserves, as of Sep 2024, the value is ₹3,500.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,678.00 Cr. (Mar 2024) to ₹3,500.00 Cr., marking a decrease of 178.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹60.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 83.00 Cr. (Mar 2024) to ₹60.00 Cr., marking a decrease of 23.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹1,481.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,411.00 Cr. (Mar 2024) to ₹1,481.00 Cr., marking an increase of 70.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹5,063.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,193.00 Cr. (Mar 2024) to ₹5,063.00 Cr., marking a decrease of 130.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹216.00 Cr.. The value appears to be declining and may need further review. It has decreased from 225.00 Cr. (Mar 2024) to ₹216.00 Cr., marking a decrease of 9.00 Cr..
For CWIP, as of Sep 2024, the value is ₹13.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to ₹13.00 Cr., marking an increase of 3.00 Cr..
For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹4,834.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,958.00 Cr. (Mar 2024) to ₹4,834.00 Cr., marking a decrease of 124.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹5,063.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,193.00 Cr. (Mar 2024) to ₹5,063.00 Cr., marking a decrease of 130.00 Cr..

Notably, the Reserves (3,500.00 Cr.) exceed the Borrowings (60.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Dec 2012	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	101	155	215	249	307	153	499	626	727	948	893	1,213
Cash from Investing Activity +	-59	-144	-187	-77	-155	-215	-257	-401	-72	-396	-148	-416
Cash from Financing Activity +	-42	-42	-58	-80	-90	-102	-143	-217	-582	-637	-639	-745
Net Cash Flow	1	-31	-30	91	62	-165	99	8	73	-86	107	52

Free Cash Flow

Month	Dec 2012	Mar 2014n n 15m	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	202.00	267.00	312.00	365.00	398.00	525.00	605.00	582.00	769.00	-151.00	-112.00	-82.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Dec 2012	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	31	18	21	20	22	29	27	28	21	21	22	20
Inventory Days	99	101	107	91	107	112	106	83	110	94	80	70
Days Payable	38	38	54	56	101	92	116	104	116	122	109	114
Cash Conversion Cycle	92	80	74	54	28	49	17	8	14	-6	-8	-24
Working Capital Days	49	36	30	32	21	63	22	14	7	-4	-5	-12
ROCE %	34%	39%	40%	38%	34%	41%	37%	35%	35%	38%	41%	46%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%
FIIs	0.22%	0.20%	0.20%	0.20%	0.19%	0.19%	0.19%	0.18%	0.18%	0.18%	0.17%	0.17%
DIIs	7.52%	7.95%	7.85%	8.38%	8.61%	8.77%	8.83%	8.73%	8.91%	8.81%	9.00%	9.01%
Public	17.27%	16.86%	16.95%	16.42%	16.20%	16.05%	16.01%	16.09%	15.92%	16.01%	15.86%	15.85%
No. of Shareholders	90,567	82,113	83,526	74,915	72,086	69,582	68,885	72,252	69,382	71,588	69,449	67,892

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Axis Midcap Fund	164,230	1.73	425.47	N/A	N/A	N/A
SBI Large & Midcap Fund	155,000	2.01	401.56	N/A	N/A	N/A
SBI Magnum Global Fund	133,000	5.29	344.56	N/A	N/A	N/A
Canara Robeco Emerging Equities	112,506	1.46	291.47	N/A	N/A	N/A
HSBC Midcap Fund	77,272	2.11	200.19	N/A	N/A	N/A
Nippon India Pharma Fund	76,390	2.87	197.9	N/A	N/A	N/A
PGIM India Midcap Opportunities Fund	66,361	1.73	171.92	N/A	N/A	N/A
Franklin India Prima Fund	52,304	1.34	135.5	N/A	N/A	N/A
Nippon India Multi Cap Fund	44,742	0.45	115.91	N/A	N/A	N/A
Canara Robeco Flexi Cap Fund	42,310	0.94	109.61	N/A	N/A	N/A

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	565.28	446.78	375.86	325.04	279.04
Diluted EPS (Rs.)	565.28	446.78	375.86	325.04	279.04
Cash EPS (Rs.)	598.77	479.71	406.96	352.38	307.09
Book Value[Excl.RevalReserv]/Share (Rs.)	1740.65	1500.49	1326.96	1224.55	1144.37
Book Value[Incl.RevalReserv]/Share (Rs.)	1740.65	1500.49	1326.96	1224.55	1144.37
Dividend / Share (Rs.)	410.00	325.00	275.00	275.00	250.00
Revenue From Operations / Share (Rs.)	2752.43	2517.05	2314.95	2028.24	1926.25
PBDIT / Share (Rs.)	800.64	639.90	548.20	471.70	409.82
PBIT / Share (Rs.)	767.15	606.97	517.10	444.34	381.76
PBT / Share (Rs.)	761.29	599.44	508.11	435.74	377.75
Net Profit / Share (Rs.)	565.28	446.78	375.86	325.03	279.04
PBDIT Margin (%)	29.08	25.42	23.68	23.25	21.27
PBIT Margin (%)	27.87	24.11	22.33	21.90	19.81
PBT Margin (%)	27.65	23.81	21.94	21.48	19.61
Net Profit Margin (%)	20.53	17.75	16.23	16.02	14.48
Return on Networth / Equity (%)	32.47	29.77	28.32	26.54	24.38
Return on Capital Employeed (%)	42.33	38.50	36.37	33.60	30.54
Return On Assets (%)	23.12	20.84	18.90	17.98	16.71
Asset Turnover Ratio (%)	1.20	1.22	1.22	1.17	1.26
Current Ratio (X)	2.42	2.51	3.20	3.41	3.60
Quick Ratio (X)	1.96	1.97	2.63	2.72	3.00
Inventory Turnover Ratio (X)	0.89	0.83	0.70	0.72	0.79
Dividend Payout Ratio (NP) (%)	57.49	61.54	0.00	0.00	23.29
Dividend Payout Ratio (CP) (%)	54.27	57.32	0.00	0.00	21.16
Earning Retention Ratio (%)	42.51	38.46	0.00	0.00	76.71
Cash Earning Retention Ratio (%)	45.73	42.68	0.00	0.00	78.84
Interest Coverage Ratio (X)	136.66	85.04	60.99	54.83	102.06
Interest Coverage Ratio (Post Tax) (X)	97.48	60.38	42.82	38.78	70.49
Enterprise Value (Cr.)	55125.76	44996.86	34862.11	29441.84	30644.48
EV / Net Operating Revenue (X)	9.42	8.41	7.09	6.83	7.49
EV / EBITDA (X)	32.40	33.09	29.93	29.37	35.19
MarketCap / Net Operating Revenue (X)	9.79	8.77	7.65	7.39	8.02
Retention Ratios (%)	42.50	38.45	0.00	0.00	76.70
Price / BV (X)	15.48	14.72	13.34	12.24	13.51
Price / Net Operating Revenue (X)	9.79	8.77	7.65	7.39	8.02
EarningsYield	0.02	0.02	0.02	0.02	0.01

After reviewing the key financial ratios for Abbott India Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 565.28. This value is within the healthy range. It has increased from 446.78 (Mar 23) to 565.28, marking an increase of 118.50.
For Diluted EPS (Rs.), as of Mar 24, the value is 565.28. This value is within the healthy range. It has increased from 446.78 (Mar 23) to 565.28, marking an increase of 118.50.
For Cash EPS (Rs.), as of Mar 24, the value is 598.77. This value is within the healthy range. It has increased from 479.71 (Mar 23) to 598.77, marking an increase of 119.06.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,740.65. It has increased from 1,500.49 (Mar 23) to 1,740.65, marking an increase of 240.16.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,740.65. It has increased from 1,500.49 (Mar 23) to 1,740.65, marking an increase of 240.16.
For Dividend / Share (Rs.), as of Mar 24, the value is 410.00. This value exceeds the healthy maximum of 3. It has increased from 325.00 (Mar 23) to 410.00, marking an increase of 85.00.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 2,752.43. It has increased from 2,517.05 (Mar 23) to 2,752.43, marking an increase of 235.38.
For PBDIT / Share (Rs.), as of Mar 24, the value is 800.64. This value is within the healthy range. It has increased from 639.90 (Mar 23) to 800.64, marking an increase of 160.74.
For PBIT / Share (Rs.), as of Mar 24, the value is 767.15. This value is within the healthy range. It has increased from 606.97 (Mar 23) to 767.15, marking an increase of 160.18.
For PBT / Share (Rs.), as of Mar 24, the value is 761.29. This value is within the healthy range. It has increased from 599.44 (Mar 23) to 761.29, marking an increase of 161.85.
For Net Profit / Share (Rs.), as of Mar 24, the value is 565.28. This value is within the healthy range. It has increased from 446.78 (Mar 23) to 565.28, marking an increase of 118.50.
For PBDIT Margin (%), as of Mar 24, the value is 29.08. This value is within the healthy range. It has increased from 25.42 (Mar 23) to 29.08, marking an increase of 3.66.
For PBIT Margin (%), as of Mar 24, the value is 27.87. This value exceeds the healthy maximum of 20. It has increased from 24.11 (Mar 23) to 27.87, marking an increase of 3.76.
For PBT Margin (%), as of Mar 24, the value is 27.65. This value is within the healthy range. It has increased from 23.81 (Mar 23) to 27.65, marking an increase of 3.84.
For Net Profit Margin (%), as of Mar 24, the value is 20.53. This value exceeds the healthy maximum of 10. It has increased from 17.75 (Mar 23) to 20.53, marking an increase of 2.78.
For Return on Networth / Equity (%), as of Mar 24, the value is 32.47. This value is within the healthy range. It has increased from 29.77 (Mar 23) to 32.47, marking an increase of 2.70.
For Return on Capital Employeed (%), as of Mar 24, the value is 42.33. This value is within the healthy range. It has increased from 38.50 (Mar 23) to 42.33, marking an increase of 3.83.
For Return On Assets (%), as of Mar 24, the value is 23.12. This value is within the healthy range. It has increased from 20.84 (Mar 23) to 23.12, marking an increase of 2.28.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.20. It has decreased from 1.22 (Mar 23) to 1.20, marking a decrease of 0.02.
For Current Ratio (X), as of Mar 24, the value is 2.42. This value is within the healthy range. It has decreased from 2.51 (Mar 23) to 2.42, marking a decrease of 0.09.
For Quick Ratio (X), as of Mar 24, the value is 1.96. This value is within the healthy range. It has decreased from 1.97 (Mar 23) to 1.96, marking a decrease of 0.01.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.89. This value is below the healthy minimum of 4. It has increased from 0.83 (Mar 23) to 0.89, marking an increase of 0.06.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 57.49. This value exceeds the healthy maximum of 50. It has decreased from 61.54 (Mar 23) to 57.49, marking a decrease of 4.05.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 54.27. This value exceeds the healthy maximum of 50. It has decreased from 57.32 (Mar 23) to 54.27, marking a decrease of 3.05.
For Earning Retention Ratio (%), as of Mar 24, the value is 42.51. This value is within the healthy range. It has increased from 38.46 (Mar 23) to 42.51, marking an increase of 4.05.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 45.73. This value is within the healthy range. It has increased from 42.68 (Mar 23) to 45.73, marking an increase of 3.05.
For Interest Coverage Ratio (X), as of Mar 24, the value is 136.66. This value is within the healthy range. It has increased from 85.04 (Mar 23) to 136.66, marking an increase of 51.62.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 97.48. This value is within the healthy range. It has increased from 60.38 (Mar 23) to 97.48, marking an increase of 37.10.
For Enterprise Value (Cr.), as of Mar 24, the value is 55,125.76. It has increased from 44,996.86 (Mar 23) to 55,125.76, marking an increase of 10,128.90.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 9.42. This value exceeds the healthy maximum of 3. It has increased from 8.41 (Mar 23) to 9.42, marking an increase of 1.01.
For EV / EBITDA (X), as of Mar 24, the value is 32.40. This value exceeds the healthy maximum of 15. It has decreased from 33.09 (Mar 23) to 32.40, marking a decrease of 0.69.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 9.79. This value exceeds the healthy maximum of 3. It has increased from 8.77 (Mar 23) to 9.79, marking an increase of 1.02.
For Retention Ratios (%), as of Mar 24, the value is 42.50. This value is within the healthy range. It has increased from 38.45 (Mar 23) to 42.50, marking an increase of 4.05.
For Price / BV (X), as of Mar 24, the value is 15.48. This value exceeds the healthy maximum of 3. It has increased from 14.72 (Mar 23) to 15.48, marking an increase of 0.76.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 9.79. This value exceeds the healthy maximum of 3. It has increased from 8.77 (Mar 23) to 9.79, marking an increase of 1.02.
For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Abbott India Ltd as of April 11, 2025 is: 21,768.91

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 11, 2025, Abbott India Ltd is Overvalued by 25.21% compared to the current share price 29,108.00

Intrinsic Value of Abbott India Ltd as of April 11, 2025 is: 24,833.61

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 11, 2025, Abbott India Ltd is Overvalued by 14.68% compared to the current share price 29,108.00

Last 5 Year EPS CAGR: 14.08%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 38.17%, which is a positive sign. The stock has a low average Working Capital Days of 21.08, which is a positive sign. The company has higher reserves (2,049.46 cr) compared to borrowings (56.62 cr), indicating strong financial stability. The company has shown consistent growth in sales (3.31 cr) and profit (364.69 cr) over the years.	The stock has a high average Cash Conversion Cycle of 31.50, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Abbott India Ltd:
1. Net Profit Margin: 20.53%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 42.33% (Industry Average ROCE: 16.01%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 32.47% (Industry Average ROE: 16.31%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 97.48
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.96
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 46.4 (Industry average Stock P/E: 40.33)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Abbott India Ltd. is a Public Limited Listed company incorporated on 22/08/1944 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1944PLC007330 and registration number is 007330. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 5848.91 Cr. and Equity Capital is Rs. 21.25 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	3, Corporate Park, Mumbai Maharashtra 400071	investorrelations.india@abbott.com http://www.abbott.co.in

Management
Name	Position Held
Mr. Munir Shaikh	Chairman
Mr. Vivek V Kamath	Managing Director
Mr. Kaiyomarz Marfatia	Non Executive Director
Mr. Ambati Venu	Non Executive Director
Mr. Sabina Ewing	Non Executive Director
Ms. Anisha Motwani	Independent Director
Ms. Shalini Kamath	Independent Director
Mr. Sudarshan Jain	Independent Director
Mr. Mahadeo Karnik	Non Executive Director

FAQ

What is the intrinsic value of Abbott India Ltd?

Abbott India Ltd's intrinsic value (as of 11 April 2025) is ₹21768.91 — 25.21% lower the current market price of 29,108.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 61,855 Cr. market cap, FY2025-2026 high/low of ₹31,900/25,200, reserves of 3,500 Cr, and liabilities of 5,063 Cr.

What is the Market Cap of Abbott India Ltd?

The Market Cap of Abbott India Ltd is 61,855 Cr..

What is the current Stock Price of Abbott India Ltd as on 11 April 2025?

The current stock price of Abbott India Ltd as on 11 April 2025 is 29,108.

What is the High / Low of Abbott India Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Abbott India Ltd stocks is ₹31,900/25,200.

What is the Stock P/E of Abbott India Ltd?

The Stock P/E of Abbott India Ltd is 46.4.

What is the Book Value of Abbott India Ltd?

The Book Value of Abbott India Ltd is 1,657.

What is the Dividend Yield of Abbott India Ltd?

The Dividend Yield of Abbott India Ltd is 1.41 %.

What is the ROCE of Abbott India Ltd?

The ROCE of Abbott India Ltd is 46.0 %.

What is the ROE of Abbott India Ltd?

The ROE of Abbott India Ltd is 34.9 %.

What is the Face Value of Abbott India Ltd?

The Face Value of Abbott India Ltd is 10.0.